Home
OrbiMed Advisors III, Director: Terns Pharmaceuticals TERN Sell · Filed 24/07/17
Trade details
- Type
- Insider sale
- Amount
- $40,090
- Shares · price
- 4,009 sh · $10.00 a share
- Held after
- 4,839,412 sh
- Trade date
- 24/07/16
- Filed
- 24/07/17
- Days to filing
- 1 days
Sold 0.1% of holdings
- Share of holding sold
- 0.1%
Terns Pharmaceuticals trades, last 26 weeks
What else happened in Terns Pharmaceuticals around then
Filed or reported within 30 days of the trade day · 24/06/16~24/08/15OrbiMed Advisors III's recent trades
- OrbiMed Advisors III
Sell10b5-1 planTerns Pharmaceuticals
Sell10b5-1 planTerns Pharmaceuticals
TERN
$394.3K
39,433 sh
$394.3K
Filed 24/07/17
Traded 24/07/15
- OrbiMed Advisors III
Sell10b5-1 planTerns Pharmaceuticals
Sell10b5-1 planTerns Pharmaceuticals
TERN
$61.4K
6,142 sh
$61.4K
Filed 24/07/17
Traded 24/07/15
- OrbiMed Advisors III
Sell10b5-1 planTerns Pharmaceuticals
Sell10b5-1 planTerns Pharmaceuticals
TERN
$54K
5,401 sh
$54K
Filed 24/07/17
Traded 24/07/15
- OrbiMed Advisors III
Sell10b5-1 planTerns Pharmaceuticals
Sell10b5-1 planTerns Pharmaceuticals
TERN
$6,230
623 sh
$6,230
Filed 24/07/17
Traded 24/07/16
- OrbiMed Advisors III
Sell10b5-1 planTerns Pharmaceuticals
Sell10b5-1 planTerns Pharmaceuticals
TERN
$5,560
556 sh
$5,560
Filed 24/07/17
Traded 24/07/16